Milestone Pharmaceuticals Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Milestone Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $32.3M, a 35.7% decline year-over-year.
  • Milestone Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $47.8M, a 1448% increase from 2022.
  • Milestone Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.09M, a 38.9% decline from 2021.
  • Milestone Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $5.06M, a 93.1% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $47.8M +$44.7M +1448% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $3.09M -$1.97M -38.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $5.06M -$68.2M -93.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $73.2M -$12.2M -14.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $85.4M +$5.29M +6.61% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $80.1M Jan 1, 2018 Dec 31, 2018 10-K/A 2020-10-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.